Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02312271 · ClinicalTrials.gov registry record
Enteral Formula Tolerance of Standard Tube Feedings
A clinical trial, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- 102
- Enrollment target
NCT02312271: Completed study, sponsored by Société des Produits Nestlé (SPN).
NCT02312271 is a clinical trial that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 102 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02312271 has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
Study Summary
This prospective observational study seeks to assess ability to achieve enteral feeding goals with standard tube feeding formulas.
Interventions
- OTHER enteral formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2014-12 |
| Est. Completion | 2017-04 |
What the finished NCT02312271 record still lists
NCT02312271 is an observational study that tracks outcomes without assigning an intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which enteral formula is the first listed.
NCT02312271 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02312271 about?
NCT02312271 is a clinical study titled "Enteral Formula Tolerance of Standard Tube Feedings". This prospective observational study seeks to assess ability to achieve enteral feeding goals with standard tube feeding formulas.
What is the current status of trial NCT02312271?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2014-12. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02312271?
The interventions under investigation include: enteral formula (OTHER).
Who is sponsoring clinical trial NCT02312271?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia